{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:25:32Z","timestamp":1789745132092,"version":"4.0.1"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Abnormal branched-chained amino acids (BCAA) accumulation in cardiomyocytes is associated with cardiac remodeling in heart failure. Administration of branched-chain \u03b1-keto acid dehydrogenase (BCKD) kinase inhibitor BT2 has been shown to reduce cardiac BCAA levels and demonstrated positive effects on cardiac function in a preclinical setting. The current study is focused on evaluating the impact of BT2 on the systemic and cardiac levels of BCAA and their metabolites as well as activities of BCAA catabolic enzymes using a quantitative systems pharmacology model.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> The model is composed of an ordinary differential equation system characterizing BCAA consumption with food, disposal in the proteins, reversible branched-chain-amino-acid aminotransferase (BCAT)-mediated transamination to branched-chain keto-acids (BCKA), followed by BCKD-mediated oxidation. Activity of BCKD is regulated by the balance of BCKDK and protein phosphatase 2Cm (PP2Cm) activities, affected by BT2 treatment. Cardiac BCAA levels are assumed to directly affect left ventricular ejection fraction (LVEF). Biochemical characteristics of the enzymes are taken from the public domains, while plasma and cardiac BCAA and BCKA levels in BT2 treated mice are used to inform the model parameters.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The model provides adequate reproduction of the experimental data and predicts synchronous BCAA responses in the systemic and cardiac space, dictated by rapid BCAA equilibration between the tissues. The model-based simulations indicate maximum possible effect of BT2 treatment on BCAA reduction to be 40% corresponding to 12% increase in LVEF. Model sensitivity analysis demonstrates strong impact of BCKDK and PP2Cm activities as well as total BCKD and co-substrate levels (glutamate, ketoglutarate and ATP) on BCAA and BCKA levels.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Model based simulations confirms using of plasma measurements as a marker of cardiac BCAA changes under BCKDK inhibition. The proposed model can be used for optimization of preclinical study design for novel compounds targeting BCAA catabolism.<\/jats:p>","DOI":"10.3389\/fphar.2022.993422","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T07:14:09Z","timestamp":1669619649000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model"],"prefix":"10.3389","volume":"13","author":[{"given":"Veronika","family":"Voronova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Morias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin Jonsson","family":"Boezelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"W\u00e5gberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Henricsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Goltsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirill","family":"Peskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Sundqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11892-018-1048-7","article-title":"Branched chain amino acids in metabolic disease","volume":"18","author":"Arany","year":"2018","journal-title":"Curr. Diab. Rep."},{"key":"B2","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3389\/fendo.2020.00534","article-title":"Adverse outcomes in obese cardiac surgery patients correlates with altered branched-chain amino acid catabolism in adipose tissue and heart","volume":"11","author":"Biswas","year":"2020","journal-title":"Front. Endocrinol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/psp4.12463","article-title":"Applications of quantitative systems pharmacology in model-informed drug discovery: Perspective on impact and opportunities","volume":"8","author":"Bradshaw","year":"2019","journal-title":"CPT. Pharmacometrics Syst. Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e011625","DOI":"10.1161\/JAHA.118.011625","article-title":"Therapeutic effect of targeting branched\u2010chain amino acid catabolic flux in pressure-overload induced heart failure","volume":"8","author":"Chen","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1146\/annurev.nu.04.070184.002205","article-title":"Branched-chain amino acid metabolism","volume":"4","author":"Harper","year":"1984","journal-title":"Annu. Rev. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12986-018-0271-1","article-title":"Branched-chain amino acids in health and disease: Metabolism, alterations in blood plasma, and as supplements","volume":"15","author":"Hole\u010dek","year":"2018","journal-title":"Nutr. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/cvr\/cvr070","article-title":"Branched-chain amino acid metabolism in heart disease: An epiphenomenon or a real culprit?","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1557S","DOI":"10.1093\/jn\/135.6.1557S","article-title":"Branched-chain [corrected] amino acid metabolism: Implications for establishing safe intakes","volume":"135","author":"Hutson","year":"2005","journal-title":"J. Nutr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1080\/00224065.1981.11978748","article-title":"An approach to sensitivity analysis of computer models: Part I\u2014introduction, input variable selection and preliminary variable assessment","volume":"13","author":"Iman","year":"1981","journal-title":"J. Qual. Technol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0134184","DOI":"10.1371\/journal.pone.0134184","article-title":"The metabolome in Finnish carriers of the MYBPC3-q1061x mutation for hypertrophic cardiomyopathy","volume":"10","author":"J\u00f8rgenrud","year":"2015","journal-title":"PLOS ONE"},{"key":"B11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00125-003-1129-1","article-title":"Direct and indirect effects of amino acids on hepatic glucose metabolism in humans","volume":"46","author":"Krebs","year":"2003","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2337\/diabetes.51.3.599","article-title":"Mechanism of amino acid-induced skeletal muscle insulin resistance in humans","volume":"51","author":"Krebs","year":"2002","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2016.11.005","article-title":"Defective branched-chain amino acid catabolism disrupts glucose metabolism and sensitizes the heart to ischemia-reperfusion injury","volume":"25","author":"Li","year":"2017","journal-title":"Cell Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5623","DOI":"10.7150\/thno.44836","article-title":"Branched chain amino acids exacerbate myocardial ischemia\/reperfusion vulnerability via enhancing GCN2\/ATF6\/PPAR-\u03b1 pathway-dependent fatty acid oxidation","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"866172796","DOI":"10.1016\/j.ejphar.2019.172796","article-title":"PP2Cm overexpression alleviates MI\/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice","volume":"866","author":"Lian","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cmet.2018.10.013","article-title":"Quantitative analysis of the whole-body metabolic fate of branched-chain amino acids","volume":"29","author":"Neinast","year":"2019","journal-title":"Cell Metab."},{"key":"B17","volume-title":"Quantitative and systems pharmacology in the post-genomic era: New approaches to discovering drugs and understanding therapeutic mechanisms","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.oooo.2014.04.003","article-title":"Glucose and glutamine metabolism in oral squamous cell carcinoma: Insight from a quantitative metabolomic approach","volume":"118","author":"Ogawa","year":"2014","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0003-9861(84)90361-8","article-title":"Regulation of branched-chain alpha-ketoacid dehydrogenase kinase","volume":"231","author":"Paxton","year":"1984","journal-title":"Arch. Biochem. Biophys."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1073\/pnas.75.10.4881","article-title":"Purification and characterization of branched chain alpha-keto acid dehydrogenase complex of bovine kidney","volume":"75","author":"Pettit","year":"1978","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.hepres.2004.09.001","article-title":"Regulation of branched-chain amino acid metabolism and pharmacological effects of branched-chain amino acids","volume":"30","author":"Shimomura","year":"2004","journal-title":"Hepatol. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00075197-200109000-00013","article-title":"Regulation of branched-chain amino acid catabolism: Nutritional and hormonal regulation of activity and expression of the branched-chain \u03b1-keto acid dehydrogenase kinase","volume":"4","author":"Shimomura","year":"2001","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ajcn\/68.1.72","article-title":"A molecular model of human branched-chain amino acid metabolism","volume":"68","author":"Suryawan","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"20583","DOI":"10.1074\/jbc.M114.569251","article-title":"Benzothiophene carboxylate derivatives as novel allosteric inhibitors of branched-chain \u03b1-ketoacid dehydrogenase kinase","volume":"289","author":"Tso","year":"2014","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"9728","DOI":"10.1073\/pnas.1303220110","article-title":"Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain \u03b1-ketoacid dehydrogenase kinase","volume":"110","author":"Tso","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","article-title":"Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure","volume":"18","author":"Uddin","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"108811","DOI":"10.1016\/j.jnutbio.2021.108811","article-title":"Disordered branched chain amino acid catabolism in pancreatic islets is associated with postprandial hypersecretion of glucagon in diabetic mice","volume":"97","author":"Wada","year":"2021","journal-title":"J. Nutr. Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","article-title":"Branched-chain \u03b1-ketoacids are preferentially reaminated and activate protein synthesis in the heart","volume":"12","author":"Walejko","year":"2021","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"H1160","DOI":"10.1152\/ajpheart.00114.2016","article-title":"Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction","volume":"311","author":"Wang","year":"2016","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"9178","DOI":"10.1074\/jbc.M111.314963","article-title":"Structural and biochemical characterization of human mitochondrial branched-chain \u03b1-ketoacid dehydrogenase phosphatase","volume":"287","author":"Wynn","year":"2012","journal-title":"J. Biol. Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"39660","DOI":"10.1074\/jbc.M607552200","article-title":"Human mitochondrial branched chain aminotransferase isozyme: Structural role of the CXXC center in catalysis","volume":"281","author":"Yennawar","year":"2006","journal-title":"J. Biol. Chem."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","article-title":"Targeting BCAA catabolism to treat obesity-associated insulin resistance","volume":"68","author":"Zhou","year":"2019","journal-title":"Diabetes"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.993422\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T07:14:14Z","timestamp":1669619654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.993422\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":33,"alternative-id":["10.3389\/fphar.2022.993422"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.993422","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]},"article-number":"993422"}}